The Oncology Brothers Rahul Gosain, MD, and Rohit Gosain, MD are joined by Rana McKay, MD, to review data from three key clinical trials in GU cancer following updates at ESMO 2023.
Data Dialogue with the Oncology Brothers
The oncology Brothers Rohit Gosain, MD, and Rahul Gosain, MD, are joined by expert Stephen Liu, MD, to review key data from the IALSC 2023 World Conference on Lung Cancer and consider their impact on clinical practice.
The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Muhammad Shaalan Beg, MD, to discuss recent data updates in gastrointestinal cancers from clinical trials presented at the 2023 ASCO Annual Meeting.
The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Toni Choueiri, MD, following the 2023 ASCO Annual Meeting to discuss recent data updates in the genitourinary cancer space.
The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Charu Aggarwal, MD, MPH, to discuss recent lung cancer data updates from clinical trials presented at the 2023 ASCO Annual Meeting.
The Oncology Brothers, joined by key opinion leader Stephanie Graff, MD, FACP, review clinical data from three key studies in breast cancer management and consider how they will impact the broader treatment landscape.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
3
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
